Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00868088 · ClinicalTrials.gov registry record · Phase 4
Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip
A Phase 4 study of Actinic Cheilitis and Squamous Cell Carcinoma In-situ (SCC-is), sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT00868088 is a Phase 4 study of Actinic Cheilitis and Squamous Cell Carcinoma In-situ (SCC-is) that has completed, run by Tufts Medical Center. The registered enrollment target is 34 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00868088, a Phase 4 study of Actinic Cheilitis and Squamous Cell Carcinoma In-situ (SCC-is), has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
Our study is designed to evaluate the efficacy of photodynamic therapy (PDT) for treatment of actinic cheilitis (AC) and as an adjunct to Mohs surgery for squamous cell carcinoma (SCC) on the lips. This study will utilize an FDA approved PDT modality (DUSA, Inc., Wilmington, MA 01887) using topical 5-amino-levulinic acid (ALA) for photosensitization followed by exposure to a Blu-U light source emitting 405-420nm wavelength light.
Conditions Studied
Interventions
- PROCEDURE PDT prior to Mohs surgery
Study Locations (1)
Massachusetts
- Tufts Medical Center, Department of Dermatology - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00868088
The ClinicalTrials.gov registry entry for NCT00868088 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Actinic Cheilitis appearing as the primary indexed condition, and to 1 intervention - of which PDT prior to Mohs surgery is the first listed.
NCT00868088 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00868088 about?
NCT00868088 is a clinical study titled "Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip". Our study is designed to evaluate the efficacy of photodynamic therapy (PDT) for treatment of actinic cheilitis (AC) and as an adjunct to Mohs surgery for squamous cell carcinoma (SCC) on the lips. This study will utilize an FDA approved PDT modality (DUSA, Inc., Wilmington, MA 01887) using topical ...
What is the current status of trial NCT00868088?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2009-07. Estimated completion is 2010-09.
What conditions does trial NCT00868088 study?
This clinical trial studies the following conditions: Actinic Cheilitis, Squamous Cell Carcinoma In-situ (SCC-is), Squamous Cell Carcinoma (SCC), Photodynamic Therapy (PDT), Mohs Surgery.
What interventions are being tested in trial NCT00868088?
The interventions under investigation include: PDT prior to Mohs surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00868088?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00868088 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Actinic Cheilitis
All registered trials for this condition
Squamous Cell Carcinoma In-situ (SCC-is)
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.